DE2366394C1 - 4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparation - Google Patents

4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparation

Info

Publication number
DE2366394C1
DE2366394C1 DE2366394A DE2366394A DE2366394C1 DE 2366394 C1 DE2366394 C1 DE 2366394C1 DE 2366394 A DE2366394 A DE 2366394A DE 2366394 A DE2366394 A DE 2366394A DE 2366394 C1 DE2366394 C1 DE 2366394C1
Authority
DE
Germany
Prior art keywords
benzo
cyclohepta
thiophen
general formula
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2366394A
Other languages
German (de)
Inventor
Jean-Pierre Magden Bourquin
Gustav Allschwil Schwarb
Erwin Aesch Waldvogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Sandoz Patent GmbH
Original Assignee
Sandoz AG
Sandoz Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG, Sandoz Patent GmbH filed Critical Sandoz AG
Application granted granted Critical
Publication of DE2366394C1 publication Critical patent/DE2366394C1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80Seven-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)

Description

in der R1 Wasserstoff oder einen in 6- oder 7-Stellung ständigen Halogen- oder niederen Alkoxyrest bedeutet und R2 für niederes Alkyl steht.in which R 1 is hydrogen or a halogen or lower alkoxy radical in the 6- or 7-position and R 2 is lower alkyl.

2. Verfahren zur Herstellung der Verbindungen nach Anspruch 1 dadurch gekennzeichnet, daß man Verbindungen der allgemeinen Formel III,2. Process for the preparation of the compounds according to claim 1, characterized in that one Compounds of the general formula III,

fflffl

in der R1 die im Anspruch 1 angegebene Bedeutung besitzt und X für Chlor oder Brom steht, mit Alkanolen der allgemeinen Formel IV,in which R 1 has the meaning given in claim 1 and X is chlorine or bromine, with alkanols of the general formula IV,

R2OH IVR 2 OH IV

in der R2 die im Anspruch 1 angegebene Bedeutung besitzt, umsetzt und die erhaltenen Verbindungen der allgemeinen Formel II,in which R 2 has the meaning given in claim 1, reacts and the compounds of the general formula II obtained,

OR2 OR 2

in der R1, R1 und X die angegebenen Bedeutungen besitzen, einer HX-Abspaltung in an sich bekannter Weise unterwirft.in which R 1 , R 1 and X have the meanings given, subjected to an HX elimination in a manner known per se.

Die Erfindung betrifft Verbindungen der allgemeinen Formel I,The invention relates to compounds of the general formula I,

OR-OR-

in der R1 die angegebene Bedeutung besitzt und X für Chlor oder Brom steht, mit Alkanolen der allgemeinen Formel IV,in which R 1 has the meaning given and X stands for chlorine or bromine, with alkanols of the general formula IV,

R2OHR 2 OH

in der R2 die angegebene Bedeutung besitzt, umsetzt und die erhaltenen Verbindungen der allgemeinen Formel II,in which R 2 has the meaning given, reacts and the compounds of the general formula II obtained,

OR2 OR 2

in der R', R2 und X die angegebene Bedeutung besitzen, einer HX-Abspaltung in an sich bekannter Weise unterwirft. in which R ', R 2 and X have the meaning given, subjected to an HX elimination in a manner known per se.

so Die Umsetzung erfolgt zweckmäßig unter Erwärmen, vorzugsweise unter Rückflußtemperatur. Die Zugabe von Silbernitrat, z. B. etwa 1 Mol bezogen auf 1 Mol Verbindung der allgemeinen Formel III, beschleunigt die Reaktion und erlaubt eine Umsetzung bei niedriger Temperatür, z. B. bei Raumtemperatur. Bei der Umsetzung entstehen als einheitliches Reaktionsprodukt Verbindungen der allgemeinen Formel II: Die Äthergruppe wird überraschenderweise praktisch quantitativ in ΙΟ-Stellung des Tricyclus eingeführt.The reaction is expediently carried out with heating, preferably under reflux temperature. The addition of Silver nitrate, e.g. B. about 1 mole based on 1 mole of the compound of general formula III, accelerates the reaction and allows implementation at a low temperature, e.g. B. at room temperature. During the implementation arise as a uniform reaction product compounds of the general formula II: The ether group is surprisingly introduced practically quantitatively in the ΙΟ-position of the tricycle.

Die Säure HX wird unter alkalischen Bedingungen abgespalten, beispielsweise durch Behandlung der Verbindungen der allgemeinen Formel II mit einer Lösung von Kaliumhydroxid in einem unter den herrschenden Bedingungen inerten organischen Lösungsmittel, wie Methanol.The acid HX is split off under alkaline conditions, for example by treating the compounds of the general formula II with a solution of potassium hydroxide in one of the prevailing Conditions of inert organic solvents such as methanol.

Die Verbindungen der allgemeinen Formel I stellen wertvolle Zwischenprodukte dar. Sie können zur Herstellung pharmakologisch wirksamer Verbindungen, z. B.The compounds of general formula I are valuable intermediates. They can be used for the preparation pharmacologically active compounds, e.g. B.

von 4-Piperidyliden-4H-benzo[4,5]cyclohepta[l ,2-b]of 4-piperidylidene-4H-benzo [4,5] cyclohepta [l, 2-b]

thiophen-I0(9H)-onen, verwendet werden.thiophene-I0 (9H) -ones can be used.

Beispiel 1example 1

10-Methoxy4H-benzo[4,5]cyclohepta[l,2-b]
thiophen-4-on
10-methoxy4H-benzo [4,5] cyclohepta [1,2-b]
thiophen-4-one

a) 9-Brom-9,10-dihydro-10-methoxy-4H-benzo[4,5] cycIohepta[l,2-b]thiophen-4-on (Verbindung der Formel II)a) 9-Bromo-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (compound of Formula II)

1010

Eine Suspension von 20 g 9,10-Dibrom-9,I0-dihydro-4H-benzo[4,5]cyclohepta[l,2-b]thiophen-4-on in 400 cm3 Methanol wird 5 Stunden unter Rückfluß gekocht. Man erhält 9-Brom-9,10-dihydro-10-methoxy-4H-benzo[4,5] cyclohepta[l,2-b]thiophen-4-on (F. 103 bis 106° C).A suspension of 20 g of 9,10-dibromo-9,10-dihydro-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one in 400 cm 3 of methanol is refluxed for 5 hours. 9-Bromo-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (melting point 103 to 106 ° C.) is obtained.

b) 10-methoxy-4H-benzo[4,5]cyclohepta[l ,2-b] thiophen-4-onb) 10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one

Zu einer Lösung von 17,5 g 9-Brom-9,10-dihydro-10-methoxy^H-benzo^^lcycloheptatl^-blthiophen^-on in 400 cm3 Methanol werden 9 g Kaliumhydroxid gegeben und die Lösung 6 Stunden unter Rückfluß gekocht. Nach dem Abkühlen auf 0 bis 5° C wird das ausgefallene Kristallisat abfiltriert und aus Methanol umkristallisiert. Auf diese Weise wird das reine 10-Methoxy-4H-benzo[4,5]cyclohepta[l,2-b]thiophen-4-on erhalten, welches bei 164 bis 166° C schmilzt. Die Mikroanalyse stimmt auf die Formel C14H10O2S. Die Struktur wurde mit Hilfe der NMR- und MS-Spektren ermittelt.To a solution of 17.5 g of 9-bromo-9,10-dihydro-10-methoxy ^ H-benzo ^^ lcycloheptatl ^ -blthiophen ^ -one in 400 cm 3 of methanol, 9 g of potassium hydroxide are added and the solution under Refluxed. After cooling to 0 to 5 ° C., the precipitated crystals are filtered off and recrystallized from methanol. In this way the pure 10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one, which melts at 164 to 166 ° C., is obtained. The microanalysis agrees with the formula C 14 H 10 O 2 S. The structure was determined with the aid of the NMR and MS spectra.

Beispiel 2Example 2

Analog Beispiel 1 und unter Verwendung folgender Verbindungen der Formel IIAnalogously to Example 1 and using the following compounds of the formula II

- 9-Brom-6-chlor-9,10-dihydro-10-methoxy-4H-benzo [4,5]cyclohepta[l,2-b]thiophen-4-on(F. 134 bis 136° C),- 9-Bromo-6-chloro-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (melting point 134 to 136 ° C),

- 9-Brom-7-chlor-9,10-dihydro-10-methoxy-4H-benzo [4,5]cyclohepta[l,2-b]thiophen-4-on (F. 135 bis 137° C),- 9-Bromo-7-chloro-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (melting point 135 to 137 ° C),

- 6,9-Dibrom-9,10-dihydro-10-methoxy-4H-benzo[4,5] cyclohepta[ 1,2-b]thiophen-4-on,- 6,9-dibromo-9,10-dihydro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one,

- 9-Brom-9,10-dihydro-7,10-dimethoxy-4H-benzo[4,5] cyclohepta[l ,2-b]thiophen-4-on,- 9-Bromo-9,10-dihydro-7,10-dimethoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one,

- 9-Brom-10-butoxy-9,10-dihydro-4H-benzo[4,5] cyclohepta[l,2-b]thiophen-4-on (F. 90 bis 9Γ C) und- 9-Bromo-10-butoxy-9,10-dihydro-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (m.p. 90 to 9Γ C) and

- 9-Brom-10-äthoxy-9,10-dihydro-4H-benzo[4,5] cycloheptaD ,2-b]thiophen-4-on- 9-Bromo-10-ethoxy-9,10-dihydro-4H-benzo [4,5] cycloheptaD, 2-b] thiophen-4-one

gelangt man zu folgenden Verbindungen der Formel I:the following compounds of the formula I are obtained:

- 6-ChIor-l0-methoxy-4H-benzo[4,5]cyclohepta[l ,2-b] thiophen-4-on (F. 220 bis 222° C),- 6-chloro-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (m.p. 220 to 222 ° C),

- 7-Chlor-10-methoxy-4H-benzo[4,5]cyclohepta[!,2-b] thiophen-4-on (F. 216 bis 218° C),- 7-chloro-10-methoxy-4H-benzo [4,5] cyclohepta [!, 2-b] thiophen-4-one (melting point 216 to 218 ° C),

- 6-Brom-10-methoxy-4H-benzo[4,5]cyclohepta[l,2-b] thiophen-4-on,- 6-Bromo-10-methoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one,

- 7,10-Dimethoxy-4H-benzo[4,5]cyclohepta[l ,2-b] thiophen-4-on (F. 83 bis 85° C),- 7,10-Dimethoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (melting point 83 to 85 ° C),

- 10-Butoxy-4H-benzo[4,5]cyc!ohepta[l,2-b] thiophen-4-on (F. 83 bis 85° C) und- 10-Butoxy-4H-benzo [4,5] cyc! Ohepta [1,2-b] thiophen-4-one (mp 83 to 85 ° C) and

- 10-Äthoxy-4H-benzo[4,5]cyclohepta[l ,2-b] thiophen-4-on (F. 127 bis 129° C).- 10-Ethoxy-4H-benzo [4,5] cyclohepta [1,2-b] thiophen-4-one (m.p. 127-129 ° C).

- Leerseite -- blank page -

Claims (1)

Patentansprüche:Patent claims: 1. 4H-Benzo[4,5]cydohepta[l,2-b]thiophen-4-one
der allgemeinen Formel I,
1. 4H-Benzo [4,5] cydohepta [1,2-b] thiophen-4-ones
of the general formula I,
OR2OR2 in der R1 Wasserstoff oder einen in 6- oder 7-Stellung ständigen Halogen- oder niederen Alkoxyrest bedeutet und R2 für niederes Alkyl steht.in which R 1 is hydrogen or a halogen or lower alkoxy radical in the 6- or 7-position and R 2 is lower alkyl. Stellt R1 Halogen dar, so steht Halogen insbesondere für Chlor oder Brom, vorzugsweise für Chlor.If R 1 is halogen, halogen is in particular chlorine or bromine, preferably chlorine. Stellt R1 eine niedere Alkoxygruppe dar, so kann diese insbesondere 1 bis 4 Kohlenstoffatome enthalten und steht vorzugsweise für die Methoxygruppe.If R 1 represents a lower alkoxy group, this can in particular contain 1 to 4 carbon atoms and preferably represents the methoxy group. Das Symbol R2 steht insbesondere für eine niedere ίο/ Alkylgruppe von 1 bis 4 Kohlenstoffatomen, vorzugsweise für Methyl.The symbol R 2 stands in particular for a lower ίο / alkyl group of 1 to 4 carbon atoms, preferably for methyl. Erfindungsgemäß gelangt man zu den Verbindungen der allgemeinen Formel I, indem man Verbindungen der allgemeinen Formel III,According to the invention, the compounds of general formula I are obtained by adding compounds of general formula III,
DE2366394A 1972-01-24 1973-01-22 4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparation Expired DE2366394C1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH98572A CH568312A5 (en) 1972-01-24 1972-01-24

Publications (1)

Publication Number Publication Date
DE2366394C1 true DE2366394C1 (en) 1983-01-20

Family

ID=4199789

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2302970A Expired DE2302970C3 (en) 1972-01-24 1973-01-22 Process for the preparation of 4- (1-substituted-4-piperidylidene) -4H-benzo [4,5] cyclohepta [1,2-b] thiophene-10 (9H) -ones
DE2366394A Expired DE2366394C1 (en) 1972-01-24 1973-01-22 4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2302970A Expired DE2302970C3 (en) 1972-01-24 1973-01-22 Process for the preparation of 4- (1-substituted-4-piperidylidene) -4H-benzo [4,5] cyclohepta [1,2-b] thiophene-10 (9H) -ones

Country Status (29)

Country Link
JP (2) JPS566997B2 (en)
KR (1) KR780000049B1 (en)
AR (1) AR202094A1 (en)
AT (1) AT334897B (en)
AU (1) AU477308B2 (en)
BE (1) BE794370A (en)
CA (1) CA1006523A (en)
CH (1) CH568312A5 (en)
CS (1) CS183674B2 (en)
DD (1) DD104084A5 (en)
DE (2) DE2302970C3 (en)
DK (2) DK154296C (en)
ES (1) ES410855A1 (en)
FI (1) FI60396C (en)
FR (2) FR2169091B1 (en)
GB (2) GB1422443A (en)
HK (1) HK53480A (en)
HU (1) HU164966B (en)
IE (1) IE38148B1 (en)
IL (1) IL41374A (en)
LU (1) LU66876A1 (en)
NL (1) NL178970C (en)
NO (1) NO136978C (en)
PL (1) PL83921B1 (en)
RO (1) RO63566A (en)
SE (1) SE395696B (en)
SU (1) SU509237A3 (en)
YU (1) YU36173B (en)
ZA (1) ZA73494B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377967B2 (en) 2008-01-30 2013-02-19 Nippon Zoki Pharmaceutical Co., Ltd. Piperidine derivative
TWI457341B (en) * 2008-08-01 2014-10-21 Nippon Zoki Pharmaceutical Co Aminopropyl derivative
JP5083989B2 (en) * 2008-11-20 2012-11-28 日本臓器製薬株式会社 Medicaments containing piperidine derivatives
CN104817532B (en) * 2015-03-04 2017-07-25 浙江工业大学 A kind of preparation method of the ketone of 10 methoxyl group 4H benzos [4,5] cycloheptatriene [1,2 b] thiazole 4

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Also Published As

Publication number Publication date
DD104084A5 (en) 1974-02-20
DE2302970C3 (en) 1982-03-18
AU5137873A (en) 1974-07-25
FR2401153B1 (en) 1983-01-14
FI60396B (en) 1981-09-30
NO136978C (en) 1977-12-07
LU66876A1 (en) 1973-07-27
ZA73494B (en) 1974-09-25
NL178970C (en) 1986-06-16
HU164966B (en) 1974-05-28
JPS5716109B2 (en) 1982-04-02
DK154296C (en) 1989-04-03
DK555680A (en) 1980-12-29
DE2302970B2 (en) 1981-06-25
BE794370A (en) 1973-07-23
NL178970B (en) 1986-01-16
NO136978B (en) 1977-08-29
FR2169091B1 (en) 1979-06-29
CS183674B2 (en) 1978-07-31
DK161324C (en) 1991-12-09
FR2169091A1 (en) 1973-09-07
YU36173B (en) 1982-02-25
NL7300797A (en) 1973-07-26
IL41374A0 (en) 1973-03-30
JPS4881869A (en) 1973-11-01
IL41374A (en) 1976-08-31
YU17873A (en) 1981-06-30
GB1422443A (en) 1976-01-28
FR2401153A1 (en) 1979-03-23
RO63566A (en) 1978-08-15
IE38148L (en) 1973-07-24
JPS55129282A (en) 1980-10-06
AU477308B2 (en) 1976-10-21
ATA47873A (en) 1976-06-15
JPS566997B2 (en) 1981-02-14
DK161324B (en) 1991-06-24
FI60396C (en) 1982-01-11
CA1006523A (en) 1977-03-08
DK238090A (en) 1990-10-02
SU509237A3 (en) 1976-03-30
AR202094A1 (en) 1975-05-15
SE395696B (en) 1977-08-22
IE38148B1 (en) 1978-01-04
GB1422444A (en) 1976-01-28
DE2302970A1 (en) 1973-08-02
DK154296B (en) 1988-10-31
PL83921B1 (en) 1976-02-28
ES410855A1 (en) 1976-03-01
DK238090D0 (en) 1990-10-02
CH568312A5 (en) 1975-10-31
KR780000049B1 (en) 1978-03-16
HK53480A (en) 1980-10-03
AT334897B (en) 1977-02-10

Similar Documents

Publication Publication Date Title
DE69206745T2 (en) PRODUCTION OF NEOPENTYL GLYCOL
DE2366394C1 (en) 4H-Benzo [4,5] cyclohepta [1,2-b] thiophene-4-one and its preparation
DE1670306A1 (en) Process for the preparation of 5-phenyl-1H-1,5-benzodiazepine-2,4-diones
DE68920298T2 (en) Process for the preparation of 4-acetoxyazetidinones.
DE1288086B (en)
DE2642608A1 (en) 4-HYDROXYMETHYL-2-PYRROLIDINONE AND THE METHOD FOR THEIR PRODUCTION
AT259562B (en) Process for the preparation of benzodiazepine derivatives
DE1218453B (en) Process for the preparation of 5,5'-dialkyl-10,10'-spiro-bis-phenaza compounds
DE573190C (en) Process for the preparation of derivatives of alpha-alpha-alpha-tribromoethane
AT257617B (en) Process for the preparation of benzodiazepine derivatives
DE3735862C2 (en)
DE1643322A1 (en) Azidozimtaldehydes and process for their preparation
DE1793711B2 (en) Process for the preparation of an unsaturated aldehyde
DE1211181B (en) Process for the preparation of azulenes substituted in the 1- and / or 3-position
AT210428B (en) Process for the preparation of new pyrido-benzothiazine derivatives substituted with a monovalent sulfur function
AT215430B (en) Process for the production of new ferrocene derivatives
AT262294B (en) Process for the preparation of benzodiazepine derivatives and the corresponding 4-deoxy compounds and salts
AT318154B (en) METHOD OF MANUFACTURING NEW STEROIDS
AT272337B (en) Process for the preparation of new 5-nitroimidazole derivatives
AT219616B (en) Process for the production of dibenzyltin dichloride or dibenzyltin dichlorides substituted in the benzene nucleus
DE2356999A1 (en) 1,2-DIHYDROINDENE-2-SPIRO-2'-PIPERAZINE DERIVATIVES AND THE METHOD FOR THEIR PRODUCTION
DE2113254C3 (en) Process for the preparation of γ-piperidinoburyrophenone derivatives
DD272854A1 (en) METHOD FOR PRODUCING 3 BETA-SUBSTITUTED (20S) -20-ARYL-SULFONYLMETHYL-PREGNA-5,7-DIENES
DE2615706C2 (en) Process for the preparation of o- (N-monosubstituted-amino) -benzyl alcohols
DE2163029C3 (en) 4-Substituted 1-Oxide-6,7-methylenedioxy-3-quinolinecarboxylic acid derivatives

Legal Events

Date Code Title Description
AC Divided out of

Ref country code: DE

Ref document number: 2302970

Format of ref document f/p: P

8100 Publication of patent without earlier publication of application
AC Divided out of

Ref country code: DE

Ref document number: 2302970

Format of ref document f/p: P

D1 Grant (no unexamined application published) patent law 81
8364 No opposition during term of opposition